Tiantian Liu

5.1k total citations · 1 hit paper
159 papers, 3.4k citations indexed

About

Tiantian Liu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Tiantian Liu has authored 159 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 40 papers in Immunology and 19 papers in Oncology. Recurrent topics in Tiantian Liu's work include Immunotherapy and Immune Responses (15 papers), interferon and immune responses (13 papers) and T-cell and B-cell Immunology (10 papers). Tiantian Liu is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), interferon and immune responses (13 papers) and T-cell and B-cell Immunology (10 papers). Tiantian Liu collaborates with scholars based in China, United States and Japan. Tiantian Liu's co-authors include Hong‐Bing Shu, Shigeyuki Hamori, Heng Lin, Ming‐Ming Hu, Bo Zhong, Kenneth M. Murphy, Yan‐Yi Wang, Qing Yang, Lei Yin and Xueqin Xie and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Tiantian Liu

149 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

2020 356 citations Vivek Durai, Derek J. Theisen et al. profile →

Peers

Countries citing papers authored by Tiantian Liu

Since Specialization

Citations

This map shows the geographic impact of Tiantian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiantian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiantian Liu more than expected).

Fields of papers citing papers by Tiantian Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiantian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiantian Liu. The network helps show where Tiantian Liu may publish in the future.

Co-authorship network of co-authors of Tiantian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Tiantian Liu. A scholar is included among the top collaborators of Tiantian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiantian Liu. Tiantian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hallmarks of the Aging Skin Microenvironment: Components and Mechanisms 2025 ·Journal of Cellular Physiology ·Ruizhe He, (unknown), Tiantian Liu, (unknown), (unknown), Xu Peng, Yinbo Peng, Yong Fang	0
2	Low-salt organohydrogel electrolytes for wide-potential-window flexible all-solid-state supercapacitors 2024 ·Applied Energy ·Ying Chen, (unknown), Yue Huang, (unknown), Tiantian Liu, (unknown), Jingwen Hu, (unknown), Jianteng Sun, (unknown), Junfu Wei, Huan Zhang, Xiaoqing Zhang, Huicai Wang	16
3	Targeting MDM2-p53 interaction in Glioblastoma: Transcriptomic analysis and Peptide-Based inhibition strategy 2024 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), Imran Iqbal, Xiao Hu, Yiting Liu, Qing Tang, (unknown), (unknown), Tiantian Liu	3
4	Can NFTs hedge the risk of traditional assets after the COVID-19 pandemic? 2024 ·The North American Journal of Economics and Finance ·Wenting Zhang, Tiantian Liu, Yulian Zhang, Shigeyuki Hamori	4
5	Oridonin, a small molecule inhibitor of cancer stem cell with potent cytotoxicity and differentiation potential 2024 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Yan Chen, (unknown), Tiantian Liu, (unknown), Yue Wang, Mengnan Zhao, Xiaofang Li, Sanjun Shi	5
6	Genome‐Based Molecular Diversity of Extended‐Spectrum β‐Lactamase‐Producing Escherichia coli From Pigeons in China 2024 ·Transboundary and Emerging Diseases ·Shuangyu Li, (unknown), (unknown), Yuhua Zhang, Lu Zheng, Juan Wang, Ruichao Li, Peng Xie, (unknown), (unknown), Qian Mao, Leilei Sun, Shanshan Li, (unknown), Fang Wang, Jianguo Liu, Tiantian Liu, Wei Pan, (unknown)	1
7	Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities 2024 ·Frontiers in Oncology ·Tiantian Liu, Yanmei Gu, Yuyu Zhang, Yumin Li	1
8	High-performance micro supercapacitor assembled by laser-induced graphene electrode and hydrogel electrolyte with excellent interfacial wettability for high capacitance 2024 ·Journal of Power Sources ·Tiantian Liu, (unknown), (unknown), Jingwen Hu, Ying Chen, Yue Huang, (unknown), (unknown), (unknown), Jianteng Sun, Junfu Wei, Huan Zhang, Xiaoqing Zhang, Huicai Wang	16
9	Alanine, a potential amino acid biomarker of pediatric sepsis: a pilot study in PICU 2024 ·Amino Acids ·Tiantian Liu, Yaya Xu, Shaohua Hu, (unknown), Hong Zhang, (unknown), Chunxia Wang	0
10	Understanding the time-dependent effect of built environment attributes on station-level metro ridership uncertainty in Beijing: A big data analytic approach 2023 ·Tunnelling and Underground Space Technology ·Chuan Ding, Tiantian Liu, Baozhen Yao, Yu Zhang, (unknown)	12
11	Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor 2023 ·Journal of Controlled Release ·Tiantian Liu, Zehang Zhou, Mengxing Zhang, (unknown), Jing Li, Zhenmi Liu, Zhirong Zhang, Lin Li, Ling Zhang	60
12	Progress in TLE treatment from 2003 to 2023: scientific measurement and visual analysis based on CiteSpace 2023 ·Frontiers in Neurology ·(unknown), (unknown), (unknown), Tiantian Liu, (unknown), (unknown), Min Zhang, (unknown)	1
13	Bcl6 , Irf2 , and Notch2 promote nonclassical monocyte development 2023 ·Proceedings of the National Academy of Sciences ·Kevin O’Connor, Tiantian Liu, Sun Kyung Kim, Carlos G. Briseño, Katia Georgopoulos, Theresa L. Murphy, Kenneth M. Murphy	6
14	Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma 2023 ·Precision Clinical Medicine ·Tiantian Liu, Zhong Chen, Wanqiu Chen, Ryan Evans, Jane Xu, Mark E. Reeves, Michael E. de Vera, Charles Wang	7
15	Success Rate and Clinical Outcomes of External Cephalic Version with or without Anesthesia for Breech Presentation at Term in China 2023 ·SHILAP Revista de lepidopterología ·Jing Yang, (unknown), Tiantian Liu, (unknown), (unknown), Tingting Sun, (unknown), Qin Wang, (unknown)	1
16	High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity 2020 ·Immunity ·Sun Kyung Kim, Prachi Bagadia, David A. Anderson, Tiantian Liu, Xiao Huang, Derek J. Theisen, Kevin O’Connor, Ray A. Ohara, Arifumi Iwata, Theresa L. Murphy, Kenneth M. Murphy	53
17	Establishment of an immortalized stromal cell line derived from human Endometriotic lesion 2020 ·Reproductive Biology and Endocrinology ·Zhixiong Huang, Rongfeng Wu, (unknown), (unknown), Tiantian Liu, Qionghua Chen, (unknown)	4
18	An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development 2019 ·Nature Immunology ·Prachi Bagadia, Xiao Huang, Tiantian Liu, Vivek Durai, Gary E. Grajales‐Reyes, Maximilian Nitschké, Zora Modrušan, Jeffrey M. Granja, Ansuman T. Satpathy, Carlos G. Briseño, Marco Gargaro, Arifumi Iwata, Sun Kyung Kim, Howard Y. Chang, Andréy S. Shaw, Theresa L. Murphy, Kenneth M. Murphy	79
19	The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors 2014 ·Endocrine Related Cancer ·Tiantian Liu, T Brown, C. Christofer Juhlin, Adam Andreasson, (unknown), Martin Bäckdahl, James M. Healy, Manju L. Prasad, Reju Korah, Tobias Carling, Dawei Xu, Catharina Larsson	65
20	WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-κB activation 2009 ·Proceedings of the National Academy of Sciences ·Yan‐Yi Wang, Lijuan Liu, Bo Zhong, Tiantian Liu, Ying Li, Yan Yang, Yong Ran, Shu Li, Po Tien, Hong‐Bing Shu	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact